{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:42:50Z","timestamp":1792100570983,"version":"4.4.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Research Centre Egypt"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cervical cancer remains one of the most prevalent gynecological malignancies worldwide, with high mortality rates particularly in developing countries, necessitating the development of effective and targeted therapeutic strategies. In this study, a folic acid (FA)-loaded amino-functionalized MCM-41 mesoporous silica nanocarrier was developed as a controlled delivery platform for cervical cancer applications. Pure MCM-41 was synthesized via a precipitation method and subsequently functionalized with aminopropyl groups through post-synthesis grafting, followed by FA-loading. Structural, textural and morphological analyses confirmed successful functionalization while maintaining the ordered mesoporous framework. In vitro drug release studies demonstrated pH-responsive behavior, with enhanced folic acid release under physiological conditions (pH 7.4) compared to acidic conditions (pH 1.5), supporting its suitability for controlled delivery applications. Cytotoxicity evaluation using HeLa cervical cancer cells and WI38 normal fibroblasts revealed selective anticancer activity of FA-functionalized systems with minimal toxicity toward normal cells. Among all formulations, the DMSO-based FA-loaded MCM-41 exhibited the highest cytotoxic and apoptotic effects, comparable to Doxorubicin. Mechanistic studies indicated that treatment induced oxidative stress through increased nitric oxide and malondialdehyde levels, accompanied by depletion of antioxidant enzymes (SOD and GSH). Additionally, apoptosis induction was confirmed by an increased Bax\/Bcl-2 ratio and activation of the intrinsic mitochondrial pathway, along with suppression of PI3K\/AKT survival signaling, along with downregulation of p-AKT. In conclusion, the developed FA-loaded amino-functionalized MCM-41 nanocarrier demonstrates efficient tumor targeting, controlled drug release, and potent apoptosis-mediated anticancer activity, highlighting its potential as a promising platform for cervical cancer therapy.<\/jats:p>","DOI":"10.1038\/s41598-026-65500-w","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T04:16:53Z","timestamp":1786594613000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Folic acid\u2013loaded amino-functionalized MCM-41 as a drug delivery system for cervical cancer modulating apoptotic and survival signals"],"prefix":"10.1038","volume":"16","author":[{"given":"Rabab K.","family":"Khaled","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Abd-Rabou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdah","family":"Dawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Ahmed","family":"Wahba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"65500_CR1","first-page":"48","volume":"41","author":"KJCI Mackenzie","year":"2021","unstructured":"Mackenzie, K. J. C. I. Investigation on bioactivity and cytotoxicity of mesoporous nano-composite MCM-48\/hydroxyapatite for ibuprofen drug delivery. Ceram. Int. 41, 48 (2021).","journal-title":"Ceram. Int."},{"key":"65500_CR2","first-page":"12","volume":"45","author":"S Yakubu","year":"2010","unstructured":"Yakubu, S. & Muazu, J. J. D. C. S. Effects of variables on degradation of folic acid. Der Chem. Sin. 45, 12 (2010).","journal-title":"Der Chem. Sin."},{"issue":"2","key":"65500_CR3","first-page":"483","volume":"57","author":"S Popescu","year":"2016","unstructured":"Popescu, S. et al. Multifunctional materials such as MCM-41\/Fe3O4\/folic acid as drug delivery system. Rom. J. Morphol. Embryol. 57(2), 483\u2013489 (2016).","journal-title":"Rom. J. Morphol. Embryol."},{"issue":"2","key":"65500_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.mehy.2011.10.023","volume":"78","author":"PH Hwang","year":"2012","unstructured":"Hwang, P. H., Lian, L. & Zavras, A. I. J. M. H. Alcohol intake and folate antagonism via CYP2E1 and ALDH1: Effects on oral carcinogenesis. Med. Hypotheses 78(2), 197\u2013202 (2012).","journal-title":"Med. Hypotheses"},{"issue":"2","key":"65500_CR5","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3945\/jn.110.131235","volume":"141","author":"TI Ibiebele","year":"2011","unstructured":"Ibiebele, T. I. et al. High intake of folate from food sources is associated with reduced risk of esophageal cancer in an Australian population. J. Nutr. 141(2), 274\u2013283 (2011).","journal-title":"J. Nutr."},{"key":"65500_CR6","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.3760\/cma.j.issn.0366-6999.20130391","volume":"126","author":"W-M Dai","year":"2013","unstructured":"Dai, W.-M. et al. Association between folate intake, serum folate levels and the risk of lung cancer: a systematic review and meta-analysis. Chin. Med. J. 126, 1957\u20131964 (2013).","journal-title":"Chin. Med. J."},{"issue":"7","key":"65500_CR7","doi-asserted-by":"publisher","first-page":"517","DOI":"10.7326\/0003-4819-129-7-199810010-00002","volume":"129","author":"E Giovannucci","year":"1998","unstructured":"Giovannucci, E. et al. Multivitamin use, folate, and colon cancer in women in the Nurses\u2019 Health Study. Ann. Intern. Med. 129(7), 517\u2013524 (1998).","journal-title":"Ann. Intern. Med."},{"issue":"9","key":"65500_CR8","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1038\/bjc.2014.155","volume":"110","author":"P Chen","year":"2014","unstructured":"Chen, P. et al. Higher dietary folate intake reduces the breast cancer risk: A systematic review and meta-analysis. Br. J. Cancer 110(9), 2327\u20132338 (2014).","journal-title":"Br. J. Cancer"},{"issue":"1","key":"65500_CR9","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3892\/ol.2015.3963","volume":"11","author":"W Zou","year":"2016","unstructured":"Zou, W. et al. BRIP1 inhibits the tumorigenic properties of cervical cancer by regulating RhoA GTPase activity. Oncol. Lett. 11(1), 551\u2013558 (2016).","journal-title":"Oncol. Lett."},{"issue":"1","key":"65500_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12885-015-1016-4","volume":"15","author":"M Segovia-Mendoza","year":"2015","unstructured":"Segovia-Mendoza, M. et al. Antihormonal agents as a strategy to improve the effect of chemo-radiation in cervical cancer: In vitro and in vivo study. BMC Cancer 15(1), 21 (2015).","journal-title":"BMC Cancer"},{"issue":"06","key":"65500_CR11","first-page":"261","volume":"58","author":"TH Lippert","year":"2008","unstructured":"Lippert, T. H., Ruoff, H.-J. & Volm, M. J. A. Intrinsic and acquired drug resistance in malignant tumors. Arzneimittelforschung 58(06), 261\u2013264 (2008).","journal-title":"Arzneimittelforschung"},{"key":"65500_CR12","doi-asserted-by":"crossref","unstructured":"Jemal, A., et al. Cancer statistics. 59(4) 225\u2013249.","DOI":"10.3322\/caac.20006"},{"key":"65500_CR13","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ijid.2014.07.029","volume":"29","author":"MF Shaltout","year":"2014","unstructured":"Shaltout, M. F. et al. Prevalence and type distribution of human papillomavirus among women older than 18 years in Egypt: a multicenter, observational study. Int. J. Infect. Dis. 29, 226\u2013231 (2014).","journal-title":"Int. J. Infect. Dis."},{"issue":"11","key":"65500_CR14","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1021\/cr940351u","volume":"99","author":"KE Uhrich","year":"1999","unstructured":"Uhrich, K. E. et al. Polymeric systems for controlled drug release. Chem. Rev. 99(11), 3181\u20133198 (1999).","journal-title":"Chem. Rev."},{"issue":"4","key":"65500_CR15","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S0142-9612(02)00364-2","volume":"24","author":"M Changez","year":"2003","unstructured":"Changez, M. et al. The effect of composition of poly (acrylic acid)\u2013gelatin hydrogel on gentamicin sulphate release: in vitro. Biomaterials 24(4), 527\u2013536 (2003).","journal-title":"Biomaterials"},{"issue":"8","key":"65500_CR16","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1002\/adfm.200601191","volume":"17","author":"II Slowing","year":"2007","unstructured":"Slowing, I. I. et al. Mesoporous silica nanoparticles for drug delivery and biosensing applications. Adv Funct. Mater. 17(8), 1225\u20131236 (2007).","journal-title":"Adv Funct. Mater."},{"issue":"16","key":"65500_CR17","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.1039\/c0jm03851b","volume":"21","author":"Q He","year":"2011","unstructured":"He, Q. & Shi, J. J. J. O. M. C. Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility. J. Mater. Chem. 21(16), 5845\u20135855 (2011).","journal-title":"J. Mater. Chem."},{"issue":"8","key":"65500_CR18","first-page":"813","volume":"12","author":"S Nastase","year":"2014","unstructured":"Nastase, S. et al. Mesostructured silica matrix for irinotecan delivery systems. Central Eur. J. Chem. 12(8), 813\u2013820 (2014).","journal-title":"Central Eur. J. Chem."},{"issue":"5","key":"65500_CR19","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.addr.2012.07.018","volume":"65","author":"V Mamaeva","year":"2013","unstructured":"Mamaeva, V., Sahlgren, C. & Lind\u00e9n, M. J. A. D. D. R. Mesoporous silica nanoparticles in medicine\u2014Recent advances. Adv. Drug Deliv. Rev. 65(5), 689\u2013702 (2013).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"65500_CR20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.colsurfb.2013.01.022","volume":"106","author":"IF Alexa","year":"2013","unstructured":"Alexa, I. F. et al. A comparative study on long-term MTX controlled release from intercalated nanocomposites for nanomedicine applications. Coll. Surf. B: Biointerfaces 106, 135\u2013139 (2013).","journal-title":"Coll. Surf. B: Biointerfaces"},{"key":"65500_CR21","doi-asserted-by":"publisher","first-page":"204173141350335","DOI":"10.1177\/2041731413503357","volume":"4","author":"S Kwon","year":"2013","unstructured":"Kwon, S. et al. Silica-based mesoporous nanoparticles for controlled drug delivery. J. Tissue Eng. 4, 2041731413503357 (2013).","journal-title":"J. Tissue Eng."},{"issue":"1","key":"65500_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/cplu.201402369","volume":"80","author":"N\u017d Kne\u017eevi\u0107","year":"2015","unstructured":"Kne\u017eevi\u0107, N. \u017d & Durand, J. O. J. C. Targeted treatment of cancer with nanotherapeutics based on mesoporous silica nanoparticles. ChemPlusChem 80(1), 26\u201336 (2015).","journal-title":"ChemPlusChem"},{"issue":"1","key":"65500_CR23","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s10971-015-3844-8","volume":"77","author":"LBDO Freitas","year":"2016","unstructured":"Freitas, L. B. D. O. et al. Mesoporous silica materials functionalized with folic acid: Preparation, characterization and release profile study with methotrexate. J. Sol-Gel Sci. Technol. 77(1), 186\u2013204 (2016).","journal-title":"J. Sol-Gel Sci. Technol."},{"issue":"1","key":"65500_CR24","doi-asserted-by":"publisher","first-page":"5725","DOI":"10.1038\/s41598-025-89522-y","volume":"15","author":"MA Wahba","year":"2025","unstructured":"Wahba, M. A., Khaled, R. K. & Dawy, M. J. S. R. Tailored bimetallic Zn\/Ni and Zn\/Ag MCM-41 photocatalysts for enhanced visible-light photocatalytic tetracycline degradation. Sci. Rep. 15(1), 5725 (2025).","journal-title":"Sci. Rep."},{"issue":"1\u20133","key":"65500_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.micromeso.2009.01.006","volume":"121","author":"H Ritter","year":"2009","unstructured":"Ritter, H. et al. A comparative study of the functionalization of mesoporous silica MCM-41 by deposition of 3-aminopropyltrimethoxysilane from toluene and from the vapor phase. Microporous Mesoporous Mater. 121(1\u20133), 79\u201383 (2009).","journal-title":"Microporous Mesoporous Mater."},{"issue":"1","key":"65500_CR26","doi-asserted-by":"publisher","first-page":"14278","DOI":"10.1038\/s41598-019-50721-z","volume":"9","author":"M Baibarac","year":"2019","unstructured":"Baibarac, M. et al. Optical properties of folic acid in phosphate buffer solutions: The influence of pH and UV irradiation on the UV-VIS absorption spectra and photoluminescence. Sci. Rep. 9(1), 14278 (2019).","journal-title":"Sci. Rep."},{"issue":"6","key":"65500_CR27","doi-asserted-by":"publisher","first-page":"pdb-prot095505","DOI":"10.1101\/pdb.prot095505","volume":"2018","author":"P Kumar","year":"2018","unstructured":"Kumar, P., Nagarajan, A. & Uchil, P. D. J. C. S. H. P. Analysis of cell viability by the MTT assay. Cold Spring Harbor Protoc. 2018(6), pdb-prot095505 (2018).","journal-title":"Cold Spring Harbor Protoc."},{"key":"65500_CR28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.cattod.2018.07.054","volume":"323","author":"G-N Yun","year":"2019","unstructured":"Yun, G.-N. et al. Infrared spectroscopic studies of the hydrodeoxygenation of \u03b3-valerolactone on Ni2P\/MCM-41. Catal. Today 323, 54\u201361 (2019).","journal-title":"Catal. Today"},{"issue":"9","key":"65500_CR29","doi-asserted-by":"publisher","first-page":"871","DOI":"10.2298\/JSC210219034A","volume":"86","author":"KK Abbasi","year":"2021","unstructured":"Abbasi, K. K. et al. Enhanced gas permeation performance of mixed matrix membranes containing polysulfone and modified mesoporous MCM-41. J. Serbian Chem. Soc. 86(9), 871\u2013887 (2021).","journal-title":"J. Serbian Chem. Soc."},{"key":"65500_CR30","doi-asserted-by":"publisher","first-page":"141875","DOI":"10.1016\/j.molstruc.2025.141875","volume":"1334","author":"HK Abd El-Mawgoud","year":"2025","unstructured":"Abd El-Mawgoud, H. K. et al. Synthesis, DFT analysis, and molecular docking of pyrazole derivatives as targeted inhibitors of PI3K\/AKT and JAK\/STAT pathways in lung cancer cells. J. Mol. Struct. 1334, 141875 (2025).","journal-title":"J. Mol. Struct."},{"key":"65500_CR31","first-page":"114643","volume":"147","author":"MA Wahba","year":"2024","unstructured":"Wahba, M. A. Boosted visible light dye-decontamination and colossal dielectric constant features of Bi2O3: Role of In, Cu and Li-dopants. J. Phys. Chem. Solids 147, 114643 (2024).","journal-title":"J. Phys. Chem. Solids"},{"issue":"6","key":"65500_CR32","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.1007\/s10904-024-03533-2","volume":"35","author":"MA Wahba","year":"2025","unstructured":"Wahba, M. A. et al. V\/Zn Incorporated-MCM-41: Synthesis, characterization and visible light photocatalytic activity for Tetracycline degradation. J. Inorg. Organomet. Polym. Mater. 35(6), 4445\u20134464 (2025).","journal-title":"J. Inorg. Organomet. Polym. Mater."},{"issue":"1\u20132","key":"65500_CR33","first-page":"93","volume":"310","author":"KM Parida","year":"2009","unstructured":"Parida, K. M. & Rath, D. J. J. O. M. C. A. C. Amine functionalized MCM-41: An active and reusable catalyst for Knoevenagel condensation reaction. J. Mol. Catal. A: Chem. 310(1\u20132), 93\u2013100 (2009).","journal-title":"J. Mol. Catal. A: Chem."},{"key":"65500_CR34","first-page":"20","volume":"17","author":"MD Badry","year":"2021","unstructured":"Badry, M. D. et al. Hydrothermally assisted synthesis of magnetic iron oxide-chitosan nanocomposites: Electrical and biological evaluation. Challenge 17, 20 (2021).","journal-title":"Challenge"},{"issue":"3","key":"65500_CR35","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1080\/15533174.2016.1186064","volume":"47","author":"MD Badry","year":"2017","unstructured":"Badry, M. D. et al. Synthesis, characterization, and in vitro anticancer evaluation of iron oxide\/chitosan nanocomposites. Inorg. Nano-Metal Chem. 47(3), 405\u2013411 (2017).","journal-title":"Inorg. Nano-Metal Chem."},{"issue":"43","key":"65500_CR36","doi-asserted-by":"publisher","first-page":"29449","DOI":"10.1039\/C7CP05177H","volume":"19","author":"G Gatti","year":"2017","unstructured":"Gatti, G. et al. The influence of particle size of amino-functionalized MCM-41 silicas on CO2 adsorption. Phys. Chem. Chem. Phys. 19(43), 29449\u201329460 (2017).","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"1\u20132","key":"65500_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.molcata.2007.10.013","volume":"280","author":"SK Sharma","year":"2008","unstructured":"Sharma, S. K., Patel, H. A. & Jasra, R. V. J. J. O. M. C. A. C. Synthesis of jasminaldehyde using magnesium organo silicate as a solid base catalyst. J. Mol. Catal. A: Chem. 280(1\u20132), 61\u201367 (2008).","journal-title":"J. Mol. Catal. A: Chem."},{"issue":"9","key":"65500_CR38","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1021\/la991176l","volume":"16","author":"S Suvanto","year":"2000","unstructured":"Suvanto, S. et al. High-cobalt-loaded MCM-41 via the gas-phase method. Langmuir 16(9), 4109\u20134115 (2000).","journal-title":"Langmuir"},{"key":"65500_CR39","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.foodchem.2015.09.017","volume":"196","author":"\u00c9 P\u00e9rez-Esteve","year":"2016","unstructured":"P\u00e9rez-Esteve, \u00c9. et al. Encapsulation of folic acid in different silica porous supports: A comparative study. Food Chem. 196, 66\u201375 (2016).","journal-title":"Food Chem."},{"issue":"1\u20132","key":"65500_CR40","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.molcata.2006.11.036","volume":"267","author":"Z Liu","year":"2007","unstructured":"Liu, Z., Zhou, R. & Zheng, X. Comparative study of different methods of preparing CuO-CeO2 catalysts for preferential oxidation of CO in excess hydrogen. J. Mol. Catal. A: Chem. 267(1\u20132), 137\u2013142 (2007).","journal-title":"J. Mol. Catal. A: Chem."},{"issue":"1","key":"65500_CR41","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1006\/jcat.1998.2198","volume":"179","author":"P-O Larsson","year":"1998","unstructured":"Larsson, P.-O. & Andersson, A. Complete oxidation of CO, ethanol, and ethyl acetate over copper oxide supported on titania and ceria modified titania. J. Catal. 179(1), 72\u201389 (1998).","journal-title":"J. Catal."},{"issue":"1","key":"65500_CR42","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cej.2007.07.078","volume":"137","author":"M Manzano","year":"2008","unstructured":"Manzano, M. et al. Studies on MCM-41 mesoporous silica for drug delivery: Effect of particle morphology and amine functionalization. Chem. Eng. J. 137(1), 30\u201337 (2008).","journal-title":"Chem. Eng. J."},{"key":"65500_CR43","unstructured":"Guthrie, C.P. Behaviour of mesoporous silica (MCM-41) supported catalysts in degradation reactions. (2013)."},{"issue":"25","key":"65500_CR44","doi-asserted-by":"publisher","first-page":"8116","DOI":"10.1021\/ja062286z","volume":"128","author":"F Balas","year":"2006","unstructured":"Balas, F. et al. Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials. J. Am. Chem. Soc. 128(25), 8116\u20138117 (2006).","journal-title":"J. Am. Chem. Soc."},{"issue":"46","key":"65500_CR45","doi-asserted-by":"publisher","first-page":"12650","DOI":"10.1021\/jp035877+","volume":"107","author":"A Maria Chong","year":"2003","unstructured":"Maria Chong, A. & Zhao, X. J. T. J. O. P. C. B. Functionalization of SBA-15 with APTES and characterization of functionalized materials. J. Phys. Chem. B 107(46), 12650\u201312657 (2003).","journal-title":"J. Phys. Chem. B"},{"issue":"6","key":"65500_CR46","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1039\/C5TX00212E","volume":"4","author":"A Pramanik","year":"2015","unstructured":"Pramanik, A. et al. Targeted delivery of \u201ccopper carbonate\u201d nanoparticles to cancer cells in vivo. Toxicol. Res. 4(6), 1604\u20131612 (2015).","journal-title":"Toxicol. Res."},{"issue":"9","key":"65500_CR47","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.3390\/ph18091392","volume":"18","author":"F Benk\u0151","year":"2025","unstructured":"Benk\u0151, F., Krist\u00f3, K. & Sov\u00e1ny, T. J. P. Mesoporous silica nanoparticles as drug delivery systems. Pharmaceuticals 18(9), 1392 (2025).","journal-title":"Pharmaceuticals"},{"issue":"28","key":"65500_CR48","doi-asserted-by":"publisher","first-page":"8845","DOI":"10.1021\/ja0719780","volume":"129","author":"II Slowing","year":"2007","unstructured":"Slowing, I. I., Trewyn, B. G. & VS-YJJOTACS Lin,. Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins. J. Am. Chem. Soc. 129(28), 8845\u20138849 (2007).","journal-title":"J. Am. Chem. Soc."},{"key":"65500_CR49","doi-asserted-by":"publisher","first-page":"1564188","DOI":"10.3389\/fnano.2025.1564188","volume":"7","author":"R Fatima","year":"2025","unstructured":"Fatima, R., Katiyar, P. & Kushwaha, K. J. F. I. N. Recent advances in mesoporous silica nanoparticle: Synthesis, drug loading, release mechanisms, and diverse applications. Front. Nanotechnology 7, 1564188 (2025).","journal-title":"Front. Nanotechnology"},{"issue":"1","key":"65500_CR50","doi-asserted-by":"publisher","first-page":"20220867","DOI":"10.1515\/biol-2022-0867","volume":"19","author":"W Zhang","year":"2024","unstructured":"Zhang, W. et al. Mesoporous silica nanoparticles as a drug delivery mechanism. Open Life Sci. 19(1), 20220867 (2024).","journal-title":"Open Life Sci."},{"issue":"9","key":"65500_CR51","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3390\/biomedicines9091275","volume":"9","author":"E Bellotti","year":"2021","unstructured":"Bellotti, E. et al. Targeting cancer cells overexpressing folate receptors with new terpolymer-based nanocapsules: Toward a novel targeted dna delivery system for cancer therapy. Biomedicines 9(9), 1275 (2021).","journal-title":"Biomedicines"},{"issue":"1","key":"65500_CR52","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","volume":"39","author":"M Valko","year":"2007","unstructured":"Valko, M. et al. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39(1), 44\u201384 (2007).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"65500_CR53","doi-asserted-by":"crossref","unstructured":"Liou, G.-Y. & P. J. F. R. R. Storz, Reactive oxygen species in cancer. 44(5): p. 479\u2013496 (2010).","DOI":"10.3109\/10715761003667554"},{"issue":"8","key":"65500_CR54","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1038\/s44321-025-00269-5","volume":"17","author":"S Schmidt","year":"2025","unstructured":"Schmidt, S., Qiao, X. & Berg\u00f6, M. O. J. E. M. M. Effects of antioxidants on cancer progression. EMBO Mol. Med. 17(8), 1896 (2025).","journal-title":"EMBO Mol. Med."},{"key":"65500_CR55","doi-asserted-by":"publisher","first-page":"107292","DOI":"10.1016\/j.bioorg.2024.107292","volume":"146","author":"E Mansour","year":"2024","unstructured":"Mansour, E. et al. Induction of breast cancer cell apoptosis by novel thiouracil-fused heterocyclic compounds through boosting of Bax\/Bcl-2 ratio and DFT study. Bioorgan. Chem. 146, 107292 (2024).","journal-title":"Bioorgan. Chem."},{"key":"65500_CR56","doi-asserted-by":"publisher","first-page":"141471","DOI":"10.1016\/j.molstruc.2025.141471","volume":"1331","author":"E Mansour","year":"2025","unstructured":"Mansour, E. et al. Novel indoline analogues reverse resistant breast cancer via p-glycoprotein inhibition and apoptotic genes modulation. J. Mol. Struct. 1331, 141471 (2025).","journal-title":"J. Mol. Struct."},{"issue":"1","key":"65500_CR57","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s12906-025-05113-4","volume":"25","author":"AHM Kamel","year":"2025","unstructured":"Kamel, A. H. M. et al. Revealing the anticancer potential of nano-encapsulated graviola extract on tongue carcinoma (SCC154) cell line: Targeting the PI3K\/AKT\/mTOR pathway (in vitro study). BMC Complement. Med. Therapies 25(1), 352 (2025).","journal-title":"BMC Complement. Med. Therapies"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-65500-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-65500-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-65500-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T06:02:07Z","timestamp":1786600927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-65500-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["65500"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-65500-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"29 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"25288"}}